Le Fort III Distraction Osteogenesis Versus Conventional Le Fort III Osteotomy in Correction of Syndromic Midfacial Hypoplasia: A Systematic Review

Retrospective study on midfacial advancement in syndromic craniosynostosis: case series

“…Current evidences suggest that Le Fort III and monobloc frontofacial surgical techniques following distraction, allow larger midfacial projections with lower relapse rates and, therefore, greater stability …”

“…The gold standard surgical treatments include: cranial expansion to release the synostotic sutures during the first year of life, Le Fort III or monobloc frontofacial osteotomy to midfacial advancement during childhood, which is followed by distraction osteogenesis (DO) …”

“…The gold standard surgical treatments include: cranial expansion to release the synostotic sutures during the first year of life, Le Fort III or monobloc frontofacial osteotomy to midfacial advancement during childhood, which is followed by distraction osteogenesis (DO). [5][6][7][8][9][10][11] The traditional DO includes surgical fracture of deformed bone, insertion of device, 5 to 7 days' rest, and gradual separation of bony segments by subsequent activation at the rate of 1 mm per day, followed by an 8 to 12 weeks consolidation phase. This allows surgeons, the lengthening and reshaping of deformed bone using internal distractors, external distractors, or a combination of both.…”

Le Fort III osteotomy for severe dentofacial deformity correction associated with hypoplasia of the midface

“…In addition, it minimizes the advancement in the Le Fort III osteotomy, reducing the need for bone grafts [14][15] .…”

“…After two years of orthodontic treatment, he showed a 15-mm maxillo-mandible discrepancy ( Figure The Le Fort III osteotomy has been widely used in dentofacial deformity treatment, primarily in syndromic patients [2][3][4][5] . It was first reported in 1950 by Gilles and Harrison 6 , and after this, Tessier 7 described the technique in more refined way, making it more applicable and predictable in craniofacial deformity treatment and revolutionizing the management in patients with total deficiency of the midface.…”